Related Experiment Videos

Are aminoglycoside antibiotics excitotoxic?

S H Sha1, J Schacht

  • 1Kresge Hearing Research Institute, Department of Otolaryngology, University of Michigan, Ann Arbor 48109-0506, USA.

Neuroreport
|January 6, 1999
PubMed

Insights

Gentamicin causes hearing loss, but maleic acid, tartaric acid, and DMSO offer protection. This suggests antioxidants may prevent aminoglycoside-induced ototoxicity.

Area of Science:

  • Ototoxicity research
  • Pharmacology
  • Neuroscience

Background:

  • Aminoglycosides, like gentamicin, are known to cause ototoxicity, leading to hearing loss.
  • The exact mechanism of gentamicin-induced hearing damage is still under investigation, with free-radical involvement being a leading hypothesis.

Purpose of the Study:

  • To investigate the protective effects of maleic acid, tartaric acid, and dimethyl sulfoxide (DMSO) against gentamicin-induced hearing loss in guinea pigs.
  • To explore the potential role of free radicals in aminoglycoside ototoxicity.

Main Methods:

  • Guinea pigs were administered gentamicin to induce hearing loss.
  • Concomitant administration of maleic acid or tartaric acid dissolved in DMSO was given to assess protective effects.
  • Auditory threshold shifts were measured to quantify hearing loss.

Main Results:

  • Gentamicin induced a significant hearing loss of 61 dB at 18 kHz.
  • Co-administration of maleic acid or tartaric acid in DMSO reduced the hearing threshold shift to below 40 dB.
  • The protective compounds act as metal chelators and free-radical scavengers.

Conclusions:

  • The findings support a free-radical mechanism in gentamicin ototoxicity.
  • Caution is advised regarding the use of maleic acid, tartaric acid, and DMSO as vehicles in ototoxicity studies.
  • Simple antioxidants may serve as an effective and economical prophylaxis against aminoglycoside-induced hearing loss.

Related Concept Videos